926 results found
Chiastra C, Grundeken M, Wu W, et al., 2015, First report on free expansion simulations of a dedicated bifurcation stent mounted on a stepped balloon, EUROINTERVENTION, Vol: 10, ISSN: 1774-024X
Sonneveld MAH, Cheng JM, Oemrawsingh RM, et al., 2015, Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome Results of the ATHEROREMO-IVUS study, THROMBOSIS AND HAEMOSTASIS, Vol: 113, Pages: 577-584, ISSN: 0340-6245
Ishibashi Y, Grundeken MJ, Nakatani S, et al., 2015, In Vitro Validation and Comparison of Different Software Packages or Algorithms for Coronary Bifurcation Analysis Using Calibrated Phantoms: Implications for Clinical Practice and Research of Bifurcation Stenting, CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol: 85, Pages: 554-563, ISSN: 1522-1946
Nakatani S, Ishibashi Y, Suwannasom P, et al., 2015, Development and Receding of a Coronary Artery Aneurysm After Implantation of a Fully Bioresorbable Scaffold, CIRCULATION, Vol: 131, Pages: 764-767, ISSN: 0009-7322
Raeber L, Taniwaki M, Zaugg S, et al., 2015, Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study, EUROPEAN HEART JOURNAL, Vol: 36, Pages: 490-500, ISSN: 0195-668X
Genereux P, Kumsars I, Lesiak M, et al., 2015, A Randomized Trial of a Dedicated Bifurcation Stent Versus Provisional Stenting in the Treatment of Coronary Bifurcation Lesions, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol: 65, Pages: 533-543, ISSN: 0735-1097
Zhang Y-J, Iqbal J, Windecker S, et al., 2015, Biolimus-eluting stent with biodegradable polymer improves clinical outcomes in patients with acute myocardial infarction, HEART, Vol: 101, Pages: 271-278, ISSN: 1355-6037
Iqbal J, Serruys PW, Albuquerque FN, et al., 2015, The year in cardiology 2014: coronary intervention, EUROPEAN HEART JOURNAL, Vol: 36, Pages: 347-+, ISSN: 0195-668X
Damen NL, Versteeg H, Serruys PW, et al., 2015, Cardiac patients who completed a longitudinal psychosocial study had a different clinical and psychosocial baseline profile than patients who dropped out prematurely, EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, Vol: 22, Pages: 196-199, ISSN: 2047-4873
Bourantas CV, Zhang Y-J, Garg S, et al., 2015, Prognostic Implications of Severe Coronary Calcification in Patients Undergoing Coronary Artery Bypass Surgery: An Analysis of the SYNTAX Study, CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol: 85, Pages: 199-206, ISSN: 1522-1946
Mushtaq S, Goncalves PDA, Garcia-Garcia HM, et al., 2015, Long-Term Prognostic Effect of Coronary Atherosclerotic Burden Validation of the Computed Tomography-Leaman Score, CIRCULATION-CARDIOVASCULAR IMAGING, Vol: 8, ISSN: 1941-9651
Mahfoud F, Serruys PW, 2015, Renal denervation reloaded: where to go from here?, EUROINTERVENTION, Vol: 10, Pages: 1135-1137, ISSN: 1774-024X
Grundeken MJ, Ishibashi Y, Genereux P, et al., 2015, Inter-Core Lab Variability in Analyzing Quantitative Coronary Angiography for Bifurcation Lesions A Post-Hoc Analysis of a Randomized Trial, JACC-CARDIOVASCULAR INTERVENTIONS, Vol: 8, Pages: 305-314, ISSN: 1936-8798
Serruys PW, 2015, Evolutions and reflections on returning from AsiaPCR/SingLIVE 2015, EuroIntervention, Vol: 10, Pages: 1133-1133, ISSN: 1774-024X
Campos CM, Ishibashi Y, Eggermont J, et al., 2015, Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model, International Journal of Cardiovascular Imaging, Vol: 31, Pages: 471-482, ISSN: 1875-8312
The objective of the study is to validate intravascular quantitative echogenicity as a surrogate for molecular weight assessment of poly-l-lactide-acid (PLLA) bioresorbable scaffold (Absorb BVS, Abbott Vascular, Santa Clara, California). We analyzed at 9 time points (from 1- to 42-month follow-up) a population of 40 pigs that received 97 Absorb scaffolds. The treated regions were analyzed by echogenicity using adventitia as reference, and were categorized as more (hyperechogenic or upperechogenic) or less bright (hypoechogenic) than the reference. The volumes of echogenicity categories were correlated with the measurements of molecular weight (Mw) by gel permeation chromatography. Scaffold struts appeared as high echogenic structures. The quantification of grey level intensity in the scaffold-vessel compartment had strong correlation with the scaffold Mw: hyperechogenicity (correlation coefficient = 0.75; P < 0.01), upperechogenicity (correlation coefficient = 0.63; P < 0.01) and hyper + upperechogenicity (correlation coefficient = 0.78; P < 0.01). In the linear regression, the R2 for high echogenicity and Mw was 0.57 for the combination of hyper and upper echogenicity. IVUS high intensity grey level quantification is correlated to Absorb BVS residual molecular weight and can be used as a surrogate for the monitoring of the degradation of semi-crystalline polymers scaffolds.
Ielasi A, Brugaletta S, Silvestro A, et al., 2015, Everolimus-eluting stent versus bare-metal stent in elderly (>= 75 years) versus non-elderly (<75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the examination trial, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 179, Pages: 73-78, ISSN: 0167-5273
Iqbal J, Serruys PW, 2015, Postprocedural Aortic Regurgitation in BalloonExpandable and Self-Expandable Transcatheter Aortic Valve Replacement Procedures: Analysis of Predictors and Impact on Long-Term Mortality: Insights From the FRANCE2 Registry, CIRCULATION, Vol: 131, Pages: E15-E15, ISSN: 0009-7322
Serruys PW, Chevalier B, Dudek D, et al., 2015, A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial, LANCET, Vol: 385, Pages: 43-54, ISSN: 0140-6736
Brugaletta S, Gori T, Low AF, et al., 2015, Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison The BVS-EXAMINATION Study (Bioresorbable Vascular Scaffold-A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction), JACC-CARDIOVASCULAR INTERVENTIONS, Vol: 8, Pages: 189-197, ISSN: 1936-8798
Muramatsu T, Garcia-Garcia HM, Brugaletta S, et al., 2015, Reproducibility of intravascular ultrasound radiofrequency data analysis (virtual histology) with a 45-MHz rotational imaging catheter in ex vivo human coronary arteries, JOURNAL OF CARDIOLOGY, Vol: 65, Pages: 134-142, ISSN: 0914-5087
Campos CM, Suwannasom P, Koenig W, et al., 2015, Darapladib for the treatment of cardiovascular disease, EXPERT REVIEW OF CARDIOVASCULAR THERAPY, Vol: 13, Pages: 33-48, ISSN: 1477-9072
van Boven N, Windecker S, Umans VA, et al., 2015, Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF, HEART, Vol: 101, Pages: 50-57, ISSN: 1355-6037
Marti V, Brugaletta S, Garcia-Picart J, et al., 2015, Radial Versus Femoral Access for Angioplasty of ST-segment Elevation Acute Myocardial Infarction With Second-generation Drug-eluting Stents, REVISTA ESPANOLA DE CARDIOLOGIA, Vol: 68, Pages: 47-53, ISSN: 0300-8932
Serruys PW, 2015, Positioning consensus for guidance, EUROINTERVENTION, Vol: 10, Pages: 1013-1014, ISSN: 1774-024X
Recommended techniques for bifurcation stenting continue to be revised with specific attention to bioresorbable scaffolds (BRS). Optimal procedural success and long-term outcomes with BRS can perhaps be improved with careful attention to implantation techniques. Good vessel preparation is imperative for optimal expansion of the scaffold, and proper vessel sizing is necessary to ensure compliance with scaffold expansion limits and preservation of proper scaffold function. The European Bifurcation Club (EBC) recommends provisional stenting for the majority of bifurcation lesions: permanent metallic stents are sized according to the distal vessel diameter, with subsequent post-dilatation of the proximal vessel to ensure stent apposition in the proximal main vessel. Recent BRS-specific modifications to the EBC recommendation suggest that selecting the scaffold size based on the diameter of the proximal main vessel can mitigate the risk of overexpansion and potential strut fracture. Expansion of the BRS requires a thoughtful balance between the risk of malapposition associated with underdeployment and the risk of strut fracture due to overdeployment. Post-dilatation of scaffolds should be performed, always respecting the maximum expansion limit, to correct any potential scaffold malapposition and minimise flow disturbances. Finally, dual antiplatelet therapy plays an important role in BRS bifurcation treatment to avoid thromboembolic events.
Left main (LM) coronary bifurcation lesions have different anatomic features from non-LM bifurcation lesions. Dedicated bifurcation devices might facilitate percutaneous coronary intervention (PCI) of LM bifurcations and improve procedural and clinical outcomes. In this review we will discuss the available clinical data on dedicated bifurcation devices for the treatment of LM bifurcation lesions. Furthermore, we will try to discuss all the theoretical advantages and potential drawbacks of these devices in terms of their use in the LM.
Campos CM, Christiansen EH, Stone GW, et al., 2015, The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation., EuroIntervention, Vol: 11 Suppl V, Pages: V115-V119
Unprotected left main coronary artery (ULMCA) stenosis has relatively high prevalence and exposes patients to a high risk for adverse cardiovascular events. The optimal revascularisation strategy (coronary artery bypass surgery [CABG] or percutaneous coronary intervention [PCI]) for patients with complex coronary artery disease is a topic of continuing debate. The introduction of the newer-generation drug-eluting stents (DES) -with documented improvements in both safety and efficacy- has prompted the interventional community to design two new dedicated randomised trials comparing CABG and PCI: the NOBLE (Coronary Artery Bypass Grafting Vs Drug Eluting Stent Percutaneous Coronary Angioplasty in the Treatment of Unprotected Left Main Stenosis) and EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trials. The aims of the present review are to describe the similarities and contrasts between these two trials as well to explore their future implications in ULMCA treatment.
Onuma Y, Okamura T, Muramatsu T, et al., 2015, New implication of three-dimensional optical coherence tomography in optimising bifurcation PCI., EuroIntervention, Vol: 11 Suppl V, Pages: V71-V74
With the advance of optical coherence tomography (OCT) technology, three-dimensional (3D) reconstruction based on the optical coherence tomography has become feasible. In bifurcation lesions, 3D OCT may guide positioning of the wire through the appropriate (distal) cells. The early studies suggested that such a guidance strategy could reduce the incidence of malapposition in bifurcation lesions. The pre-installed "real-time" 3D OCT on the console will promote the utilisation of 3D assessment in bifurcation treatment and possibly establish the clinical benefit of such guidance in the near future when investigated in a prospective study.
Serruys PW, 2015, The treatment of coronary bifurcations: a true art form., EuroIntervention, Vol: 11 Suppl V
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.